D-0339-2021 Class III Terminated

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0339-2021 was initiated by Teligent Pharma, Inc. on Feb 2, 2021 and is designated Class III. Reason for recall: Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate. The recall status is terminated (terminated Aug 15, 2024). Affected quantity: 79,416 tubes.

Recall details

Product Type
Drugs
Report Date
May 5, 2021
Initiation Date
Feb 2, 2021
Termination Date
Aug 15, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
79,416 tubes

Product description

Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 50 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-019-51

Reason for recall

Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

Distribution pattern

USA Nationwide

Code information

Lot #: 14297, Exp 9/2021; 15757, Exp 6/2022; 15840, Exp 7/2022; 15970, Exp 9/2022; 15993, Exp 9/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0339-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0339-2021. Report a data issue: hello@regdatalab.com.